nodes	percent_of_prediction	percent_of_DWPC	metapath
Lofexidine—ADRA2A—Adrenoceptors—ADRB1—type 1 diabetes mellitus	0.0679	0.0679	CbGpPWpGaD
Lofexidine—HTR1A—Monoamine GPCRs—CHRM2—type 1 diabetes mellitus	0.0416	0.0416	CbGpPWpGaD
Lofexidine—HTR1A—Amine ligand-binding receptors—CHRM2—type 1 diabetes mellitus	0.035	0.035	CbGpPWpGaD
Lofexidine—ADRA2A—Monoamine GPCRs—CHRM2—type 1 diabetes mellitus	0.0327	0.0327	CbGpPWpGaD
Lofexidine—HTR1A—Monoamine GPCRs—ADRB1—type 1 diabetes mellitus	0.0305	0.0305	CbGpPWpGaD
Lofexidine—ADRA2A—Amine ligand-binding receptors—CHRM2—type 1 diabetes mellitus	0.0275	0.0275	CbGpPWpGaD
Lofexidine—HTR1A—Amine ligand-binding receptors—ADRB1—type 1 diabetes mellitus	0.0257	0.0257	CbGpPWpGaD
Lofexidine—ADRA2A—Monoamine GPCRs—ADRB1—type 1 diabetes mellitus	0.024	0.024	CbGpPWpGaD
Lofexidine—ADRA2A—Regulation of insulin secretion—ABCC8—type 1 diabetes mellitus	0.0223	0.0223	CbGpPWpGaD
Lofexidine—ADRA2A—Amine ligand-binding receptors—ADRB1—type 1 diabetes mellitus	0.0202	0.0202	CbGpPWpGaD
Lofexidine—ADRA2A—Regulation of insulin secretion—KCNJ11—type 1 diabetes mellitus	0.0177	0.0177	CbGpPWpGaD
Lofexidine—ADRA2A—Integration of energy metabolism—ABCC8—type 1 diabetes mellitus	0.0176	0.0176	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (z) signalling events—PRKCQ—type 1 diabetes mellitus	0.0161	0.0161	CbGpPWpGaD
Lofexidine—ADRA2A—Regulation of insulin secretion—ITPR3—type 1 diabetes mellitus	0.0149	0.0149	CbGpPWpGaD
Lofexidine—ADRA2A—Integration of energy metabolism—KCNJ11—type 1 diabetes mellitus	0.0139	0.0139	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—CHRM2—type 1 diabetes mellitus	0.012	0.012	CbGpPWpGaD
Lofexidine—ADRA2A—Integration of energy metabolism—ITPR3—type 1 diabetes mellitus	0.0117	0.0117	CbGpPWpGaD
Lofexidine—ADRA2A—Regulation of insulin secretion—GCG—type 1 diabetes mellitus	0.0109	0.0109	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—SIRPG—type 1 diabetes mellitus	0.00943	0.00943	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—GAL—type 1 diabetes mellitus	0.00931	0.00931	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—CCL20—type 1 diabetes mellitus	0.0092	0.0092	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—SST—type 1 diabetes mellitus	0.00885	0.00885	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—CHRM2—type 1 diabetes mellitus	0.00865	0.00865	CbGpPWpGaD
Lofexidine—ADRA2A—Integration of energy metabolism—GCG—type 1 diabetes mellitus	0.00858	0.00858	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.00803	0.00803	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.0074	0.0074	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00732	0.00732	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00732	0.00732	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—GAL—type 1 diabetes mellitus	0.00731	0.00731	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—CCL20—type 1 diabetes mellitus	0.00723	0.00723	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00688	0.00688	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—CHRM2—type 1 diabetes mellitus	0.0068	0.0068	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—ITPR3—type 1 diabetes mellitus	0.00641	0.00641	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—SST—type 1 diabetes mellitus	0.00638	0.00638	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—CHRM2—type 1 diabetes mellitus	0.00631	0.00631	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.00631	0.00631	CbGpPWpGaD
Lofexidine—ADRA2A—Regulation of insulin secretion—INS—type 1 diabetes mellitus	0.00613	0.00613	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00589	0.00589	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—GAL—type 1 diabetes mellitus	0.00582	0.00582	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL11—type 1 diabetes mellitus	0.00575	0.00575	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCL20—type 1 diabetes mellitus	0.00575	0.00575	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00563	0.00563	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00557	0.00557	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00557	0.00557	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CHRM2—type 1 diabetes mellitus	0.00541	0.00541	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.0053	0.0053	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00524	0.00524	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00507	0.00507	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00505	0.00505	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—SST—type 1 diabetes mellitus	0.00501	0.00501	CbGpPWpGaD
Lofexidine—ADRA2A—Integration of energy metabolism—INS—type 1 diabetes mellitus	0.00482	0.00482	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB1—type 1 diabetes mellitus	0.00463	0.00463	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—PRKCQ—type 1 diabetes mellitus	0.00452	0.00452	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—GAL—type 1 diabetes mellitus	0.00443	0.00443	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.0044	0.0044	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—VAV1—type 1 diabetes mellitus	0.00439	0.00439	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CCL11—type 1 diabetes mellitus	0.00438	0.00438	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CCL20—type 1 diabetes mellitus	0.00438	0.00438	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00421	0.00421	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—SELL—type 1 diabetes mellitus	0.00421	0.00421	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—CXCL10—type 1 diabetes mellitus	0.00417	0.00417	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CHRM2—type 1 diabetes mellitus	0.00412	0.00412	CbGpPWpGaD
Lofexidine—HTR1A—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.00411	0.00411	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—SST—type 1 diabetes mellitus	0.00399	0.00399	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—IGF2—type 1 diabetes mellitus	0.00397	0.00397	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—type 1 diabetes mellitus	0.00397	0.00397	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00386	0.00386	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00385	0.00385	CbGpPWpGaD
Lofexidine—HTR1A—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.00381	0.00381	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—IAPP—type 1 diabetes mellitus	0.00346	0.00346	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00344	0.00344	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—IL2RA—type 1 diabetes mellitus	0.00334	0.00334	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—type 1 diabetes mellitus	0.00331	0.00331	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.00331	0.00331	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—ITPR3—type 1 diabetes mellitus	0.00331	0.00331	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.0033	0.0033	CbGpPWpGaD
Lofexidine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00327	0.00327	CbGpPWpGaD
Lofexidine—ADRA2A—G alpha (i) signalling events—CCR5—type 1 diabetes mellitus	0.00323	0.00323	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00321	0.00321	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.00318	0.00318	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00315	0.00315	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—SH2B3—type 1 diabetes mellitus	0.00311	0.00311	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—SST—type 1 diabetes mellitus	0.00304	0.00304	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—ADRB1—type 1 diabetes mellitus	0.00302	0.00302	CbGpPWpGaD
Lofexidine—ADRA2A—GPCRs, Class A Rhodopsin-like—CCR5—type 1 diabetes mellitus	0.003	0.003	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00296	0.00296	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00289	0.00289	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00286	0.00286	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00286	0.00286	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—GCG—type 1 diabetes mellitus	0.00271	0.00271	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00269	0.00269	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00266	0.00266	CbGpPWpGaD
Lofexidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—type 1 diabetes mellitus	0.00257	0.00257	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—type 1 diabetes mellitus	0.00255	0.00255	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CXCL10—type 1 diabetes mellitus	0.00252	0.00252	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—GAL—type 1 diabetes mellitus	0.0025	0.0025	CbGpPWpGaD
Lofexidine—HTR1A—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00249	0.00249	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—NOS1—type 1 diabetes mellitus	0.00249	0.00249	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00249	0.00249	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CCL20—type 1 diabetes mellitus	0.00247	0.00247	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HBA2—type 1 diabetes mellitus	0.00246	0.00246	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—ALB—type 1 diabetes mellitus	0.00242	0.00242	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.00241	0.00241	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—TNF—type 1 diabetes mellitus	0.0024	0.0024	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—PRKCQ—type 1 diabetes mellitus	0.00233	0.00233	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CHRM2—type 1 diabetes mellitus	0.00233	0.00233	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—G6PC2—type 1 diabetes mellitus	0.00232	0.00232	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—GAL—type 1 diabetes mellitus	0.00227	0.00227	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—VAV1—type 1 diabetes mellitus	0.00226	0.00226	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00226	0.00226	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCL11—type 1 diabetes mellitus	0.00225	0.00225	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCL20—type 1 diabetes mellitus	0.00225	0.00225	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00218	0.00218	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00217	0.00217	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CHRM2—type 1 diabetes mellitus	0.00211	0.00211	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.00209	0.00209	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—IGF2—type 1 diabetes mellitus	0.00205	0.00205	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ABCC8—type 1 diabetes mellitus	0.00201	0.00201	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00198	0.00198	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00197	0.00197	CbGpPWpGaD
Lofexidine—ADRA2A—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	0.00196	0.00196	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.00196	0.00196	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.00195	0.00195	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00195	0.00195	CbGpPWpGaD
Lofexidine—HTR1A—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	0.00194	0.00194	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.0019	0.0019	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.00187	0.00187	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00182	0.00182	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00181	0.00181	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.00177	0.00177	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00177	0.00177	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—IL2RA—type 1 diabetes mellitus	0.00172	0.00172	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.00172	0.00172	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.00171	0.00171	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.00171	0.00171	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.0017	0.0017	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00169	0.00169	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.00169	0.00169	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00165	0.00165	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.00165	0.00165	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00159	0.00159	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—KCNJ11—type 1 diabetes mellitus	0.00159	0.00159	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.00156	0.00156	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.00155	0.00155	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.00153	0.00153	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—NOS2—type 1 diabetes mellitus	0.00148	0.00148	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.00147	0.00147	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00143	0.00143	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.00143	0.00143	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.00143	0.00143	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00141	0.00141	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.00139	0.00139	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00139	0.00139	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.00134	0.00134	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00134	0.00134	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ITPR3—type 1 diabetes mellitus	0.00134	0.00134	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.00134	0.00134	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00133	0.00133	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00133	0.00133	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.00133	0.00133	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00133	0.00133	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—IGF1—type 1 diabetes mellitus	0.00131	0.00131	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.0013	0.0013	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.00129	0.00129	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.00128	0.00128	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—HBA1—type 1 diabetes mellitus	0.00126	0.00126	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.00126	0.00126	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—APOC3—type 1 diabetes mellitus	0.00125	0.00125	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.00125	0.00125	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—ALB—type 1 diabetes mellitus	0.00125	0.00125	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GSTT1—type 1 diabetes mellitus	0.00123	0.00123	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—NOS3—type 1 diabetes mellitus	0.00119	0.00119	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—SST—type 1 diabetes mellitus	0.00117	0.00117	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.00117	0.00117	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.00112	0.00112	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.00111	0.00111	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00109	0.00109	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00105	0.00105	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00105	0.00105	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00105	0.00105	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00104	0.00104	CbGpPWpGaD
Lofexidine—ADRA2A—Hemostasis—IL2—type 1 diabetes mellitus	0.00101	0.00101	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.001	0.001	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.001	0.001	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000989	0.000989	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—GCG—type 1 diabetes mellitus	0.000981	0.000981	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000976	0.000976	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000973	0.000973	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—SST—type 1 diabetes mellitus	0.00092	0.00092	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000916	0.000916	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000887	0.000887	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000883	0.000883	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000851	0.000851	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—CAT—type 1 diabetes mellitus	0.00083	0.00083	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00082	0.00082	CbGpPWpGaD
Lofexidine—HTR1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000813	0.000813	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000807	0.000807	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.00079	0.00079	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000767	0.000767	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000767	0.000767	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000765	0.000765	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000754	0.000754	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000744	0.000744	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000738	0.000738	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000697	0.000697	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000694	0.000694	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000669	0.000669	CbGpPWpGaD
Lofexidine—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000639	0.000639	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000634	0.000634	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000621	0.000621	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000603	0.000603	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000593	0.000593	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	0.000586	0.000586	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000584	0.000584	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.00058	0.00058	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000567	0.000567	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000564	0.000564	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	0.000551	0.000551	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000524	0.000524	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000514	0.000514	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	0.000505	0.000505	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000488	0.000488	CbGpPWpGaD
Lofexidine—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	0.000483	0.000483	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	0.000461	0.000461	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000446	0.000446	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000444	0.000444	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000437	0.000437	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000436	0.000436	CbGpPWpGaD
Lofexidine—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000434	0.000434	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000412	0.000412	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000404	0.000404	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000367	0.000367	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000343	0.000343	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000343	0.000343	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000341	0.000341	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000333	0.000333	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000288	0.000288	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000262	0.000262	CbGpPWpGaD
Lofexidine—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000256	0.000256	CbGpPWpGaD
Lofexidine—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	0.000201	0.000201	CbGpPWpGaD
